Solu-medrol Injection, Powder, For Solution
Product Images NDC 55154-3941

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Solu-medrol (NDC 55154-3941). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

289fe43b Bdde 422c Ac63 65795a6af311 00

The image shows a drug information panel for Solu-Medrol 125 mg vial, methylprednisolone sodium succinate injection powder for solution. It includes usage instructions for intramuscular or intravenous routes, directions for using the ACT-O-VIAL system, storage conditions, warnings, and distributor information for Pfizer and Cardinal Health.*

FDA Label Image

Bag Label (Image 01)

Solu-Medrol 40 mg per vial powder for injection, containing methylprednisolone sodium succinate. The label specifies single-dose, preservative-free vials for intramuscular or intravenous use, with 5 x 1 mL doses in ACT-O-VIAL systems. It includes usage directions, storage conditions, and manufacturer information for Cardinal Health 107, LLC.*

FDA Label Image

Chemical Structure (Solu Medrol 01)

Chemical structure of methylprednisolone sodium succinate, the active ingredient in Solu-Medrol injection powder for solution.*

FDA Label Image

Figure (Solu Medrol 02)

An instructional diagram illustrating a needle piercing a vial stopper, likely demonstrating how to access the powder for solution in an injectable vial of Solu-Medrol (methylprednisolone sodium succinate). The image focuses on the needle's insertion through the vial's rubber stopper.*

FDA Label Image

Logo (Solu Medrol 03)

Solu-Medrol injection packaging label showing the Pfizer Injectables logo, distributed by Pharmacia & Upjohn Co, a division of Pfizer Inc, New York, NY. The label primarily features branding and distributor information for methylprednisolone sodium succinate injection powder for solution, with no specific strength or dosage visible in the image.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.